Anti-B3GNT9 aptamer SELEX Service(Cat#: CTApt-1991)

This is an aptamer development services to screening aptamers binds to the B3GNT9 with an affinity of 1nM~1μM.

Specific Inquiry 
Size
5’ Modification
 
3’ Modification
 
Add To
Online Inquiry

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

TOP
Summary
Specifications
Target Category Protein
Target B3GNT9
Alternative Names UDP-GlcNAc:BetaGal Beta-1,3-N-Acetylglucosaminyltransferase 9; Beta-1,3-N-Acetylglucosaminyltransferase 9; Beta-1,3-Gn-T9; Beta3Gn-T9; BGnT-9; Beta-1,3-Galactosyltransferase-Related Protein; MGC4655; B3GNT9
Gene ID 84752
UniProt ID Q6UX72
Target Overview B3GNT9 (UDP-GlcNAc:BetaGal Beta-1,3-N-Acetylglucosaminyltransferase 9) is a Protein Coding gene. Diseases associated with B3GNT9 include Nonaka Myopathy. Among its related pathways are O-linked glycosylation and Metabolism of proteins. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring glycosyl groups and galactosyltransferase activity. An important paralog of this gene is B3GNT7.
Chemical Modification N/A
Type DNA
Length 20-80 nt
Affinity (Kd) 1nM~1μM
Binding Conditions/Buffer PBS; buffer system with Serum; other
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
Online Inquiry